These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 25961977)

  • 41. Comparison of possible carcinogenic estradiol metabolites: effects on proliferation, apoptosis and metastasis of human breast cancer cells.
    Seeger H; Wallwiener D; Kraemer E; Mueck AO
    Maturitas; 2006 Apr; 54(1):72-7. PubMed ID: 16213115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estradiol metabolism during oral and transdermal estradiol replacement therapy in postmenopausal women.
    Lippert TH; Seeger H; Mueck AO
    Horm Metab Res; 1998 Sep; 30(9):598-600. PubMed ID: 9808331
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estrogen metabolite ratio: Is the 2-hydroxyestrone to 16α-hydroxyestrone ratio predictive for breast cancer?
    Obi N; Vrieling A; Heinz J; Chang-Claude J
    Int J Womens Health; 2011 Feb; 3():37-51. PubMed ID: 21339936
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis?
    Zhu BT; Conney AH
    Cancer Res; 1998 Jun; 58(11):2269-77. PubMed ID: 9622057
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of estradiol metabolites and progestogens on the proliferation of human ovarian cancer cells.
    Seeger H; Mueck AO
    Panminerva Med; 2006 Mar; 48(1):13-7. PubMed ID: 16633327
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Breast cancer: are estrogen metabolites carcinogenic?
    Mueck AO; Seeger H
    Climacteric; 2007 Oct; 10 Suppl 2():62-5. PubMed ID: 17882675
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The significance of estrogen metabolism for hormone-dependent neoplasms from the clinical-pharmacological viewpoint].
    Lippert TH; Seeger H; Mueck AO
    Arzneimittelforschung; 1999 Aug; 49(8):649-62. PubMed ID: 10483510
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tissue-selectivity: the mechanism of action of tibolone.
    Kloosterboer HJ
    Maturitas; 2004 Aug; 48 Suppl 1():S30-40. PubMed ID: 15337246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of lifestyle factors on gynaecological cancer.
    Rieck G; Fiander A
    Best Pract Res Clin Obstet Gynaecol; 2006 Apr; 20(2):227-51. PubMed ID: 16543119
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Are estradiol metabolites involved in gynaecological carcinogenesis?
    Seeger H; Mueck AO
    Horm Mol Biol Clin Investig; 2010 Jan; 1(3):111-6. PubMed ID: 25961977
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Breast cancer: are oestrogen metabolites carcinogenic?
    Mueck AO; Seeger H
    Maturitas; 2007 May; 57(1):42-6. PubMed ID: 17383836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Estrogen-dependent neoplasia - what is the significance of estradiol metabolites].
    Mueck AO; Seeger H; Lippert TH
    Zentralbl Gynakol; 2003 Nov; 125(11):458-66. PubMed ID: 14634875
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.